Released on: October 31, 2008, 2:52 am

Press Release Author: Shushmul Maheshwari

Industry: Healthcare

Press Release Summary: Driven by a strong demand and a number of new product
launches, the global market for cancer vaccines is expected to grow robustly in next
five years.

Press Release Body: According to our report "Global Vaccine Market Forecast to
2012", addition of over 12 Million new cancer patients annually and unavailability
of an effective treatment has created a strong interest among the pharmaceutical and
biotech players in the cancer vaccine segment to come up with the most effective
treatment in the shortest time possible. The report estimates that in 2007, the
market for cancer vaccines, largely driven by the sales of cervical cancer vaccine
Gardasil, reached US$ 2.2 Billion.

This report says that the cervical vaccine segment is expected to be the most
lucrative in the cancer vaccine market. Cervical cancer vaccines Gardasil and
Cervaix were among the top three bestselling vaccines in 2012. Apart from the
cervical cancer segment - melanoma, lung lymphoma and prostate cancer vaccine
segments are also seeing high activity with a number of products in late stage of
development. However, to repeat the success of Gardasil in the market, each of these
vaccines will have to establish its superiority as well as safety in terms of the
currently established treatment protocols in order to first win the market approval
and later on get reimbursement from health insurance agencies.

A number of new approvals will push the cancer vaccine segment to grow at a CAGR of
over 30% between 2007 and 2012, enabling the cancer vaccine segment to occupy more
than 26% of the overall global vaccine market in 2012, says the research report.

Apart from cervical vaccines, "Global Vaccine Market Forecast to 2012" also talks
about vaccine segments like pneumococcal vaccines, polio vaccines, HIV vaccines,
meningitis vaccines and Japanese encephalitis vaccines among others. This report
contains market-based research and provides objective analysis on the global vaccine
market. It gives a thorough statistical and analytical overview on the global
vaccine market, and provides past, present and future data on the market structure
and composition. The research extensively discusses the opportunities and challenges
that are expected to arise within and from the vaccine market.

About RNCOS:

RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of
industry experts who analyze data collected from credible sources. They provide
industry insights and analysis that helps corporations to take timely and accurate
business decision in today's globally competitive environment.

For more information visit: http://www.rncos.com/Report/IM153.htm
Current Industry News: http://www.rncos.com/Blog/

Web Site: http://www.rncos.com/

Contact Details: 29, 1st Floor, Patparganj Industrial Area, Delhi 92
91-11-4214-1229
91-11-4214-1228
info@rncos.com

http://www.rncos.com/

press@rncos.com